Clinical Trial Update: NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration

View source ↗

Summary

The clinical trial of NewBreez for airway protection in head and neck cancer patients with chronic aspiration was terminated, and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Cancer

Drugs mentioned

• NewBreez

Snippet

Sponsor: ProTiP Medical | Conditions: Aspiration, Laryngeal Cancer | Status: TERMINATED | Results posted: 2017-08-24